Baidu
map

Lancet Oncol:TERT启动子UTSS区域高度甲基化是儿童脑肿瘤进展的预测标记

2013-08-27 echo1166 dxy

研究要点:TERT启动子甲基化可作为儿童恶性脑肿瘤的生物标记和预后判断标记。在儿童恶性脑肿瘤中,当肿瘤从低级别向高级别转化时,UTSS甲基化增加。TERT启动子UTSS区域的高度甲基化与肿瘤中TERT的表达相关。在儿科神经系统肿瘤领域中,鉴定得到对恶性疾病有提示意义的生物标记是十分重要的方面。这有助于建立评估疾病出现进展的方法。加拿大多伦多大学的Pedro Castelo-Branco等为了探



研究要点:

TERT启动子甲基化可作为儿童恶性脑肿瘤的生物标记和预后判断标记。

在儿童恶性脑肿瘤中,当肿瘤从低级别向高级别转化时,UTSS甲基化增加。

TERT启动子UTSS区域的高度甲基化与肿瘤中TERT的表达相关。

在儿科神经系统肿瘤领域中,鉴定得到对恶性疾病有提示意义的生物标记是十分重要的方面。这有助于建立评估疾病出现进展的方法。加拿大多伦多大学的Pedro Castelo-Branco等为了探究TERT启动子甲基化在儿科脑肿瘤患者中,是否能作为恶性病变的生物标记和预后判断标记而进行了相关研究,他们的研究结果发表在Lancet Oncol 7月的在线期刊上。【原文下载

在探索队列中,研究者的样本来自贮存于德国肿瘤研究中心的儿科脑肿瘤患者。在验证队列中,研究者采用来自多伦多的2家医院的数种组织以获得充分的临床和随访数据。

为了确定生物标记能否用于评估和预测患者病情的进展情况,研究者在成对的肿瘤样本中(从低级别病变转化为高级别病变,或从局灶性病变转化为转移性病变,或不同级别的脉络膜丛肿瘤)分析其甲基化状态。最后在后颅窝室管膜瘤的患者中(某一区域存在/不存在高度甲基化)调查了他们的总体生存情况。所有进行甲基化分析的研究者都不知道患者的预后情况。

研究者在探查探索队列中共对280个样本进行了分析,对确定的CpG位点(cg11625005)进行分析,其中79个样本来自于正常脑组织和低级别肿瘤组织,在这些样本中的78个(99%)没有出现高度甲基化,而在201个来自于恶性肿瘤的样本中,有145个样本(72%)为高度甲基化样本,结果具有显著统计学意义。对验证队列的68个样本在确定的5个CpG位点进行分析(转录起始位点的上游(UTSS)),结果提示在所有表达TERT的儿童恶性脑肿瘤的样本中都呈现高度甲基化,但是在没有表达TERT的健康脑组织中却并未发现高度甲基化,结果具有显著统计学意义。

UTSS的阳性预测值为1,阴性预测值为0.95。在成对的儿童胶质瘤样本中,当肿瘤从低级别向高级别转化时,UTSS甲基化增加;如果成对的肿瘤样本中从局灶性病变向转移性病变发展时,也会出现UTSS甲基化增加。

在8个高表达UTSS甲基化的非典型性乳头状瘤样本中,有2个转化成癌性病变,而其他的6个样本并未出现进展或需要进行额外治疗。在25名高度甲基化UTSS的后颅窝室管膜瘤患者,其5年总体生存率为51%,而20名非甲基化UTSS肿瘤患者5年总体生存率为95%,结果具有显著统计学意义。在25名非高度甲基化UTSS肿瘤中5年非进展生存期为86%,而甲基化的肿瘤患者则为30%。

本研究结果指出,在TERT启动子UTSS区域的高度甲基化与肿瘤中TERT的表达相关。在儿科脑肿瘤中,UTSS的高度甲基化与肿瘤进展相关,同时也与患者预后差相关。这一区域容易扩增,在绝大多数的临床实验室中容易建立出高度甲基化的序列。因此,UTSS区域对于很多肿瘤而言是一种生物标记。

研究背景:

无论是儿童还是成人,肿瘤都是造成疾病相关死亡的主要原因。很多情况,肿瘤都具有较长的病程,在从增生型病变向不典型增生性病变、癌前病变,最终至恶性肿瘤的转变期间会经历数个阶段的进展。

端粒维持是肿瘤的一个特点,是所有恶性肿瘤自我更新过程中至关重要的一个环节。端粒酶是一种维持端粒稳定的酶,在90%的晚期肿瘤中被激活,但是在绝大多数的正常组织中该酶不被激活,所以端粒酶是针对肿瘤的一个生物标记。端粒酶逆转录酶(TERT)是端粒酶复合物的催化中心。TERT仅在一些人类细胞中表达,如正常胚胎干细胞、造血祖细胞和激活的淋巴细胞。在绝大多数的恶性肿瘤细胞中记录到了TERT表达,并且与很多肿瘤(如肉瘤、脑肿瘤、结直肠肿瘤和乳腺癌)的预后差相关。

然而,约有10%的肿瘤(包括在儿童和成人中的脑肿瘤)能通过同源重组依赖的机制来维持端粒的稳定,即所谓的端粒替代延长(ALT)。在人类细胞中TERT表达严格受限,但是其机制不明。虽然有报道指出,一些癌基因和肿瘤抑制基因会与TERT启动子相结合,但是它们在TERT表达调节中所起到的作用仍然不清楚。

表观遗传学调节是一种生物学机制,通过不改变最基本的基因组序列的DNA甲基化和组蛋白修饰来调节基因表达。位于CpG启动子区域的重叠部位的胞嘧啶残基的DNA甲基化通常与沉默基因相关。在50%的人类基因中,这些CpG的序列(CpG岛)位于启动子区域。针对在TERT启动子DNA甲基化的研究结果各不相同。虽然一些研究报道低甲基化的CpG岛覆盖了TERT启动子,其他的研究则报道在肿瘤细胞中表达TERT的DNA甲基化增加。

存在上述矛盾结果的原因是研究者所针对的TERT启动子的不同区域进行研究。我们目前还不知晓启动子高度甲基化和基因表达增加之间存在何种性质的联系,但这种联系的确是存在的。此外,针对基因启动子的基因组分析显示CpG岛的高度甲基化与肿瘤相关基因的激活高度相关,这对于既往的观点做出了挑战——即CpG岛的甲基化与沉默基因相关。理解启动子甲基化状态的机制和TERT表达调节的机制或许能帮助确定有意义的临床标记。

既往研究所针对的是端粒和端粒酶在儿童脑部肿瘤形成过程中所起到的作用。脑部肿瘤占了儿童肿瘤的25%以上,并且是儿童期肿瘤致死的首要原因。在低级别的儿童脑肿瘤中端粒酶处于非激活状态,但在绝大多数的恶性肿瘤和其相应的肿瘤干细胞中则呈激活状态。此外,TERT表达在这些肿瘤中是一项重要的预后预测标志。然而,在这些研究中所使用的抗体并非特异性的,并且研究结果是不可重复的。

原始出处:

Castelo-Branco P, Choufani S, Mack S, Gallagher D, Zhang C, Lipman T, Zhukova N, Walker EJ, Martin D, Merino D, Wasserman JD, Elizabeth C, Alon N, Zhang L, Hovestadt V, Kool M, Jones DT, Zadeh G, Croul S, Hawkins C, Hitzler J, Wang JC, Baruchel S, Dirks PB, Malkin D, Pfister S, Taylor MD, Weksberg R, Tabori U.Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.Lancet Oncol. 2013 May;14(6):534-42. doi: 10.1016/S1470-2045(13)70110-4. Epub 2013 Apr 16. 【原文下载

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1737200, encodeId=143b1e3720059, content=<a href='/topic/show?id=611e8312358' target=_blank style='color:#2F92EE;'>#肿瘤进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83123, encryptionId=611e8312358, topicName=肿瘤进展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c47234265932, createdName=ms8435843352634314, createdTime=Tue May 27 09:39:00 CST 2014, time=2014-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827613, encodeId=37e5182e61329, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Jan 18 13:39:00 CST 2014, time=2014-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993983, encodeId=827619939832b, content=<a href='/topic/show?id=bbb039310b2' target=_blank style='color:#2F92EE;'>#启动子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39310, encryptionId=bbb039310b2, topicName=启动子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Apr 12 06:39:00 CST 2014, time=2014-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019956, encodeId=55e320199567d, content=<a href='/topic/show?id=de15100234f3' target=_blank style='color:#2F92EE;'>#预测标记#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100234, encryptionId=de15100234f3, topicName=预测标记)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Thu Mar 27 05:39:00 CST 2014, time=2014-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864476, encodeId=036d18644e64d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Mar 21 06:39:00 CST 2014, time=2014-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417984, encodeId=e637141e98408, content=<a href='/topic/show?id=6ba485016cd' target=_blank style='color:#2F92EE;'>#脑肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85016, encryptionId=6ba485016cd, topicName=脑肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f03326658, createdName=839640779, createdTime=Thu Aug 29 00:39:00 CST 2013, time=2013-08-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1737200, encodeId=143b1e3720059, content=<a href='/topic/show?id=611e8312358' target=_blank style='color:#2F92EE;'>#肿瘤进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83123, encryptionId=611e8312358, topicName=肿瘤进展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c47234265932, createdName=ms8435843352634314, createdTime=Tue May 27 09:39:00 CST 2014, time=2014-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827613, encodeId=37e5182e61329, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Jan 18 13:39:00 CST 2014, time=2014-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993983, encodeId=827619939832b, content=<a href='/topic/show?id=bbb039310b2' target=_blank style='color:#2F92EE;'>#启动子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39310, encryptionId=bbb039310b2, topicName=启动子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Apr 12 06:39:00 CST 2014, time=2014-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019956, encodeId=55e320199567d, content=<a href='/topic/show?id=de15100234f3' target=_blank style='color:#2F92EE;'>#预测标记#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100234, encryptionId=de15100234f3, topicName=预测标记)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Thu Mar 27 05:39:00 CST 2014, time=2014-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864476, encodeId=036d18644e64d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Mar 21 06:39:00 CST 2014, time=2014-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417984, encodeId=e637141e98408, content=<a href='/topic/show?id=6ba485016cd' target=_blank style='color:#2F92EE;'>#脑肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85016, encryptionId=6ba485016cd, topicName=脑肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f03326658, createdName=839640779, createdTime=Thu Aug 29 00:39:00 CST 2013, time=2013-08-29, status=1, ipAttribution=)]
    2014-01-18 howi
  3. [GetPortalCommentsPageByObjectIdResponse(id=1737200, encodeId=143b1e3720059, content=<a href='/topic/show?id=611e8312358' target=_blank style='color:#2F92EE;'>#肿瘤进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83123, encryptionId=611e8312358, topicName=肿瘤进展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c47234265932, createdName=ms8435843352634314, createdTime=Tue May 27 09:39:00 CST 2014, time=2014-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827613, encodeId=37e5182e61329, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Jan 18 13:39:00 CST 2014, time=2014-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993983, encodeId=827619939832b, content=<a href='/topic/show?id=bbb039310b2' target=_blank style='color:#2F92EE;'>#启动子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39310, encryptionId=bbb039310b2, topicName=启动子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Apr 12 06:39:00 CST 2014, time=2014-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019956, encodeId=55e320199567d, content=<a href='/topic/show?id=de15100234f3' target=_blank style='color:#2F92EE;'>#预测标记#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100234, encryptionId=de15100234f3, topicName=预测标记)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Thu Mar 27 05:39:00 CST 2014, time=2014-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864476, encodeId=036d18644e64d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Mar 21 06:39:00 CST 2014, time=2014-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417984, encodeId=e637141e98408, content=<a href='/topic/show?id=6ba485016cd' target=_blank style='color:#2F92EE;'>#脑肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85016, encryptionId=6ba485016cd, topicName=脑肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f03326658, createdName=839640779, createdTime=Thu Aug 29 00:39:00 CST 2013, time=2013-08-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1737200, encodeId=143b1e3720059, content=<a href='/topic/show?id=611e8312358' target=_blank style='color:#2F92EE;'>#肿瘤进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83123, encryptionId=611e8312358, topicName=肿瘤进展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c47234265932, createdName=ms8435843352634314, createdTime=Tue May 27 09:39:00 CST 2014, time=2014-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827613, encodeId=37e5182e61329, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Jan 18 13:39:00 CST 2014, time=2014-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993983, encodeId=827619939832b, content=<a href='/topic/show?id=bbb039310b2' target=_blank style='color:#2F92EE;'>#启动子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39310, encryptionId=bbb039310b2, topicName=启动子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Apr 12 06:39:00 CST 2014, time=2014-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019956, encodeId=55e320199567d, content=<a href='/topic/show?id=de15100234f3' target=_blank style='color:#2F92EE;'>#预测标记#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100234, encryptionId=de15100234f3, topicName=预测标记)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Thu Mar 27 05:39:00 CST 2014, time=2014-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864476, encodeId=036d18644e64d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Mar 21 06:39:00 CST 2014, time=2014-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417984, encodeId=e637141e98408, content=<a href='/topic/show?id=6ba485016cd' target=_blank style='color:#2F92EE;'>#脑肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85016, encryptionId=6ba485016cd, topicName=脑肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f03326658, createdName=839640779, createdTime=Thu Aug 29 00:39:00 CST 2013, time=2013-08-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1737200, encodeId=143b1e3720059, content=<a href='/topic/show?id=611e8312358' target=_blank style='color:#2F92EE;'>#肿瘤进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83123, encryptionId=611e8312358, topicName=肿瘤进展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c47234265932, createdName=ms8435843352634314, createdTime=Tue May 27 09:39:00 CST 2014, time=2014-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827613, encodeId=37e5182e61329, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Jan 18 13:39:00 CST 2014, time=2014-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993983, encodeId=827619939832b, content=<a href='/topic/show?id=bbb039310b2' target=_blank style='color:#2F92EE;'>#启动子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39310, encryptionId=bbb039310b2, topicName=启动子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Apr 12 06:39:00 CST 2014, time=2014-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019956, encodeId=55e320199567d, content=<a href='/topic/show?id=de15100234f3' target=_blank style='color:#2F92EE;'>#预测标记#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100234, encryptionId=de15100234f3, topicName=预测标记)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Thu Mar 27 05:39:00 CST 2014, time=2014-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864476, encodeId=036d18644e64d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Mar 21 06:39:00 CST 2014, time=2014-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417984, encodeId=e637141e98408, content=<a href='/topic/show?id=6ba485016cd' target=_blank style='color:#2F92EE;'>#脑肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85016, encryptionId=6ba485016cd, topicName=脑肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f03326658, createdName=839640779, createdTime=Thu Aug 29 00:39:00 CST 2013, time=2013-08-29, status=1, ipAttribution=)]
    2014-03-21 minlingfeng
  6. [GetPortalCommentsPageByObjectIdResponse(id=1737200, encodeId=143b1e3720059, content=<a href='/topic/show?id=611e8312358' target=_blank style='color:#2F92EE;'>#肿瘤进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83123, encryptionId=611e8312358, topicName=肿瘤进展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c47234265932, createdName=ms8435843352634314, createdTime=Tue May 27 09:39:00 CST 2014, time=2014-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827613, encodeId=37e5182e61329, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Jan 18 13:39:00 CST 2014, time=2014-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993983, encodeId=827619939832b, content=<a href='/topic/show?id=bbb039310b2' target=_blank style='color:#2F92EE;'>#启动子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39310, encryptionId=bbb039310b2, topicName=启动子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Apr 12 06:39:00 CST 2014, time=2014-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019956, encodeId=55e320199567d, content=<a href='/topic/show?id=de15100234f3' target=_blank style='color:#2F92EE;'>#预测标记#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100234, encryptionId=de15100234f3, topicName=预测标记)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKCRibWHQArPHdSkqP90U1HwwqlGeU7BUgzY240D3v2ibBDJ09ybkGkwOjxz7qRmngZaGlK1taX6hfA/132, createdBy=2e772500094, createdName=小华子, createdTime=Thu Mar 27 05:39:00 CST 2014, time=2014-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864476, encodeId=036d18644e64d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Mar 21 06:39:00 CST 2014, time=2014-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417984, encodeId=e637141e98408, content=<a href='/topic/show?id=6ba485016cd' target=_blank style='color:#2F92EE;'>#脑肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85016, encryptionId=6ba485016cd, topicName=脑肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f03326658, createdName=839640779, createdTime=Thu Aug 29 00:39:00 CST 2013, time=2013-08-29, status=1, ipAttribution=)]

相关资讯

ACS Nano:利用纳米粒子对免疫细胞重编程来对抗癌症

日前,科学家研发出了一种新的抗癌技术——他们使用纳米粒子来对免疫细胞进行重新编程,使其能识别并攻击癌症。研究发表在美国化学学会最新一期的《纳米》(ACS Nano)杂志上。【原文下载】 免疫系统是人体最重要的保卫系统,其主要作用是“查获”并破坏威胁人体健康的细菌和病毒,但免疫系统并非完美无缺,很多癌细胞能避开免疫系统的“火眼金睛”,因为其同正常的细胞非常像,这就使癌细胞能在身体内自由地繁殖

缅甸男子患肿瘤身高2.33米

  8月15日,温梭乌中走在缅甸仰光国际机场内 新华社/法新   家住缅甸偏远乡村的温梭乌身高2.33米,是缅甸第一高度。不过,他不久前才知道自己的身高是脑垂体肿瘤作祟的结果。在好心人的捐助下,他15日赴新加坡,准备接受手术,解除健康隐患。   温梭乌现年36岁,家住缅甸中部马圭地区的一个小村庄。父母靠种植花生和芝麻养大他和三个姐妹。进入青春期后,温梭乌的个

Cell:细胞如何给自己缓压?

自由基就像燃烧废气一样,是由于外部能源或细胞代谢所产生,会对机体细胞造成压力。人们认为细胞压力促进了癌症、神经退行性疾病和代谢性疾病等年龄相关疾病的发生。 现在,来自德国弗莱堡大学的研究人员揭示出了细胞保护自身免受压力伤害的一条新机制。他们发现,许多细胞中很少研究的一个元件 Astrin 在这一过程中发挥了重要的作用。尽管过去已知 Astrin 在细胞分裂中所起的作用,这

Nature:癌症突变具有不同特征

尽管所有癌症都被认为是由体细胞突变(身体中除生殖细胞以外的任何细胞的突变)造成的,但我们对所涉及的突变过程相对来说却知之甚少。这项研究分析了来自超过7000癌症的近500万突变,发现了超过20个与癌症相关的不同突变特征。这些特征中有些存在于很多癌症中,其中一个特征属于APOBEC家族的胞苷脱氨酶,而其他特征则是个别肿瘤类型特有的。有些特征与年龄、已知诱变因素或DNA维护中的缺陷有关,但很多的来源却

PNAS:解答10年谜题:eIF4E蛋白与癌症

很久以前研究人员就已经知道,人类细胞中一种特异的蛋白质高水平与肿瘤生长相关,但却对这一具体机制却不是很清楚。 现在,来自加州大学戴维斯分校生命科学学院的研究人员取得了一项突破性的发现,他们阐明了真核起始因子 4E(eukaryotic initiation factor 4E, eIF4E )蛋白对促癌信使 RNA 分子起作用的机制。当翻译之时,这类 mRNA 可以触发失控性

Genome Res:可以有效寻找癌症、糖尿病基因的预测模型

来自延世大学李仁锡教授,利用'机能遗传子网络'预测模型,开发的可以有效地发掘调解复杂疾患遗传子的新方法。 此次研究是通过与欧洲分子生物学研究所的Lehner博士,德克萨斯州立大学的Marcotte博士,加拿大多伦多大学的Fraser博士的国际共同研究所进行的研究,也是得到教科部及韩国研究财团的'优秀研究中心(S/ERC)育成事业'与'一半研究者支援事业'支援的随性研究。 李仁锡教授研究组利用'

Baidu
map
Baidu
map
Baidu
map